Your browser doesn't support javascript.
loading
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial.
Li, Yueping; Xie, Zhiwei; Lin, Weiyin; Cai, Weiping; Wen, Chunyan; Guan, Yujuan; Mo, Xiaoneng; Wang, Jian; Wang, Yaping; Peng, Ping; Chen, Xudan; Hong, Wenxin; Xiao, Guangming; Liu, Jinxin; Zhang, Lieguang; Hu, Fengyu; Li, Feng; Zhang, Fuchun; Deng, Xilong; Li, Linghua.
Afiliação
  • Li Y; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Xie Z; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Lin W; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Cai W; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Wen C; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Guan Y; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Mo X; Department of Respiration, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
  • Wang J; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Wang Y; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Peng P; Department of Respiration, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
  • Chen X; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Hong W; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Xiao G; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Liu J; Department of Radiology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
  • Zhang L; Department of Radiology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
  • Hu F; Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Li F; Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Zhang F; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
  • Deng X; Intensive Care Unit, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
  • Li L; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.
Med ; 1(1): 105-113.e4, 2020 12 18.
Article em En | MEDLINE | ID: mdl-32838353
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ritonavir / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ritonavir / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos